1 No-Brainer Growth Stock to Buy Now [Yahoo! Finance]
Madrigal Pharmaceuticals, Inc. (MDGL)
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am
Check Earnings Report
US:NASDAQ Investor Relations:
madrigalpharma.com
Company Research
Source: Yahoo! Finance
the S&P 500 over this period, thanks to an innovation boom spearheaded by the human genome project and ultralow interest rates. However, in 2022, a pivotal moment occurred when the Federal Reserve shifted its stance on interest rates. As a result of the central bank's decision to ratchet up rates, biotech stocks experienced a sharp decline almost across the board, plunging the industry into a bear market. With the Federal Reserve planning to reduce rates later this year, however, biotech may be poised to reclaim its position as a top area for wealth creation. One stock that could benefit from a shift in investor sentiment is Madrigal Pharmaceuticals (NASDAQ: MDGL) Madrigal's shares have modestly outperformed the S&P 500 this year, but its stock still screens as significantly undervalued. Here's why aggressive investors may want to start accumulating shares of the liver-disease specialist before the central bank starts cutting rates. Madrigal Pharmaceuticals: An intriguing valu
Show less
Read more
Impact Snapshot
Event Time:
MDGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDGL alerts
High impacting Madrigal Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
MDGL
News
- Madrigal: Rezdiffra Launch Gets Underway, The Only Competition Is Off-Label [Seeking Alpha]Seeking Alpha
- Madrigal Statement on the Passing of Dr. Stephen HarrisonGlobeNewswire
- Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage [Seeking Alpha]Seeking Alpha
- Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024GlobeNewswire